Prevalence of a Hemoglobin A1c Less Than 7.0%, of a Blood Pressure Less Than 130/80 mm Hg, and of a Serum Low-Density Lipoprotein Cholesterol Less Than 100 mg/dL in Older Patients With Diabetes Mellitus in an Academic Nursing Home

Journal of the American Medical Directors Association

Volumn 9, Issue 1, 2008, Pages 51-54

  Joseph, Julie ^a   Koka, Madhavi ^a   Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

angiotensin receptor blockers; angiotensin converting enzyme inhibitors; blood pressure; Diabetes mellitus; hemoglobin A1c; low density lipoprotein cholesterol; renal insufficiency; statins

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLIPIZIDE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC DIET; DIABETIC PATIENT; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NURSING HOME; NURSING HOME PATIENT; PRACTICE GUIDELINE; PREVALENCE; UNIVERSITY HOSPITAL; BLOOD; BLOOD PRESSURE; GERIATRIC ASSESSMENT; MIDDLE AGED; STATISTICS; UNITED STATES;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CHOLESTEROL, LDL; DIABETES MELLITUS; FEMALE; GERIATRIC ASSESSMENT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NEW YORK; NURSING HOMES; PREVALENCE;

EID: 37549055862     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2007.08.012     Document Type: Article

References (26)

1. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 26 supplement 1 (2003) 533-550
2. Smith Jr. S.C., Allen J., Blair S.N., et al. ACC/AHA guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
3. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. Brit Med J 321 (2000) 405-412
4. 1c level with the severity of coronary artery disease in patients with diabetes mellitus. Am J Cardiol 97 (2006) 968-969
5. 1c levels to severity of peripheral arterial disease in patients with diabetes mellitus. Am J Cardiol 99 (2007) 1468-1469
6. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 289 (2003) 2560-2572
7. Adler A.I., Stratton I.M., Neil H.A.W., et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. Brit Med J 321 (2000) 412-419
8. Aronow W.S. Drug therapy of older persons with hypertension. J Am Med Dir Assoc 7 (2006) 193-196
9. Koka M., Joseph J., and Aronow W.S. Adequacy of control of hypertension in an academic nursing home. J Am Med Dir Assoc 8 (2007) 538-540
10. Ziesmer V., Ghosh S., and Aronow W.S. Use of antihypertensive drug therapy in older persons in an academic nursing home. J Am Med Dir Assoc 3 (2002) 243-245
11. Grundy S.M., Cleeman J.I., Merz C.N.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
12. Aronow W.S. Updated National Cholesterol Education Program III guidelines. J Am Med Dir Assoc 6 (2005) 160-161
13. Zarowitz B.J., Aronow W.S., Hollenack K., and O'Shea T. The application of evidence-based principles of care in older persons (issue 2): Management of lipid disorders. J Am Med Dir Assoc 7 (2006) 173-179
14. Aronow W.S. Managing hyperlipidaemia in the elderly. Special considerations for a population at high risk. Drugs Aging 23 (2006) 181-189
15. Koka M., Joseph J., and Aronow W.S. Prevalence of adequate and of optimal control of serum low-density lipoprotein cholesterol in an academic nursing home. J Am Med Dir Assoc 8 (2007) 604-606
16. Ghosh S., and Aronow W.S. Utilization of lipid-lowering drugs in elderly persons with increased serum low-density lipoprotein cholesterol associated with coronary artery disease, symptomatic peripheral arterial disease, prior stroke, or diabetes mellitus before and after an educational program on dyslipidemia treatment. J Gerontol A Biol Sci Med Sci 58A (2003) M432-M435
17. National Kidney Foundation Guideline. K/DOQI clinical practice guidelines for chronic kidney disease: Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39 suppl 2 (2002) S1-S246
18. American Diabetes Association. Treatment of hypertension of adults with diabetes. Diabetes Care 26 suppl 1 (2003) 580-582
19. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130 (1999) 461-470
20. Mooradian A.D., Osterweil D., Petrasek D., and Morley J.E. Diabetes mellitus in elderly nursing home patients. A survey of clinical chartacteristics and management. J Am Geriatr Soc 36 (1988) 391-396
21. 1c monitoring in the elderly?. J Am Med Dir Assoc 7 suppl 3 (2006) S60-S64
22. Martin-Baranera M., Sanchez Ferrin P., Armario P., and Geriatric HTA Study Group. Prevalence of hypertension in elderly long-term care residents in Spain. The Geriatric HTA study. Medicina Clinica 127 (2006) 681-687
23. Thomas J.M., Alvarez W., Mulaj M., et al. Control of hypertension in nursing homes. Revue Medicale de Bruxelles 27 (2006) S271-S273
24. Aronow W.S., and Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drug. Am J Cardiol 89 (2002) 67-69
25. Aronow W.S., Ahn C., and Gutstein H. Incidence of new atherothrombotic brain infarction in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drug. J Gerontol A Biol Sci Med Sci 57A (2002) M333-M335
26. Aronow W.S., Ahn C., and Gutstein H. Reduction of new coronary events and of new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins. J Gerontol A Biol Sci Med Sci 57A (2002) M747-M750